Financial Ratios

MPS PHARMAA LTD.

NSE : NABSE : 531686ISIN CODE : INE537C01019Industry : Pharmaceuticals & DrugsHouse : Private
BSE3.060 (0 %)
PREV CLOSE ( ) 3.06
OPEN PRICE ( ) 3.06
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 500
TODAY'S LOW / HIGH ( )3.06 3.06
52 WK LOW / HIGH ( ) 23.06
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)-0.55-0.07-2.31-0.61-0.65
   CEPS(Rs)-0.470.19-2.02-0.31-0.34
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.462.002.074.384.99
   Tax Rate(%)1.9284.821.735.633.63
Margin Ratios
   Core EBITDA Margin(%)-2079.400.00-86.78
   EBIT Margin(%)-2868.330.00-155.73
   Pre Tax Margin(%)-2880.220.00-156.14
   PAT Margin (%)-437.310.00-150.47
   Cash Profit Margin (%)1149.130.00-79.48
Performance Ratios
   ROA(%)-10.33-1.32-31.87-6.87-6.79
   ROE(%)-31.75-3.64-71.73-13.04-12.28
   ROCE(%)-11.15-9.64-36.90-8.08-7.76
   Asset Turnover(x)0.000.000.000.000.05
   Sales/Fixed Asset(x)0.000.000.000.000.05
   Working Capital/Sales(x)0.00-0.010.000.00-0.43
Efficiency Ratios
   Fixed Capital/Sales(x)485.453690.3519.52
   Receivable days3546.470.001425.91
   Inventory Days6293.930.00252.48
   Payable days1303.80769.800.000.0066.41
Valuation Parameters
   PER(x)0.000.000.000.000.00
   PCE(x)-4.447.14-0.37-1.16-5.52
   Price/Book(x)1.440.690.360.080.38
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)261.011610.0711.99
   EV/Core EBITDA(x)-11.66-20.36-1.80-10.61-14.15
   EV/EBIT(x)-10.07-9.10-1.58-5.69-7.70
   EV/CE(x)1.060.830.630.430.57
   M Cap / Sales82.05157.644.38
Growth Ratio
   Net Sales Growth(%)-100.00-100.00-99.47-79.77
   Core EBITDA Growth(%)-122.6689.45-493.925.58-50.44
   EBIT Growth(%)-15.2179.32-263.634.23-22.28
   PAT Growth(%)-641.9096.79-278.506.36-43.96
   EPS Growth(%)-641.7096.79-278.466.35-43.96
Financial Stability Ratios
   Total Debt/Equity(x)2.421.521.440.760.66
   Current Ratio(x)0.290.330.330.710.74
   Quick Ratio(x)0.220.240.240.630.66
   Interest Cover(x)-990.70-241.16-1520.41-881.13-381.88
   Total Debt/Mcap(x)1.692.193.969.231.74

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.